Fate Therapeutics
FATE
#8160
Rank
โ‚ฌ0.18 B
Marketcap
1,61ย โ‚ฌ
Share price
1.20%
Change (1 day)
-48.14%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -2,09ย โ‚ฌ

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,08ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,79ย โ‚ฌ a decrease over its 2021 EPS that were of -2,14ย โ‚ฌ.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,09ย โ‚ฌ-25.12%
2022-2,79ย โ‚ฌ30.49%
2021-2,14ย โ‚ฌ7.21%
2020-1,99ย โ‚ฌ45.45%
2019-1,37ย โ‚ฌ19.17%
2018-1,15ย โ‚ฌ17.65%
2017-0,98ย โ‚ฌ-3.77%
2016-1,02ย โ‚ฌ-12.4%
2015-1,16ย โ‚ฌ-3.97%
2014-1,21ย โ‚ฌ-2.09%
2013-1,23ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-7,50ย โ‚ฌ 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
5,31ย โ‚ฌ-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-8,28ย โ‚ฌ 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,97ย โ‚ฌ 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
1,88ย โ‚ฌ-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA